ORGO
Overvalued by 80.7% based on the discounted cash flow analysis.
Market cap | $669.79 Million |
---|---|
Enterprise Value | $577.53 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.01 |
Beta | 1.8 |
Outstanding Shares | 131,673,278 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 807.47 |
---|---|
PEG | 43643.24 |
Price to Sales | 1.78 |
Price to Book Ratio | 2.67 |
Enterprise Value to Revenue | 1.27 |
Enterprise Value to EBIT | -53.21 |
Enterprise Value to Net Income | -79 |
Total Debt to Enterprise | 0.07 |
Debt to Equity | 0.16 |
No data
No data